Mechanisms of Type 2 Diabetes Remission After Bariatric and Metabolic Surgery

Mechanisms of Type 2 Diabetes Remission After Bariatric and Metabolic Surgery

Authors

  • Tamar Shervashidze David Agmashenebeli University of Georgia image/svg+xml
  • Rusudan Kvanchakhadze David Agmashenebeli University of Georgia image/svg+xml
  • Davit Abuladze Davit Abuladze Georgian-Italian Clinic
  • Lia Jashi David Agmashenebeli University of Georgia image/svg+xml

DOI:

https://doi.org/10.52340/spectri.2024.09.01.22

Keywords:

Type 2 diabetes, Bariatric surgery, Gastric bypass, Obesity, Sleeve gastrectomy

Abstract

Obesity and diabetes mellitus are two closely related disorders that increase the incidence of morbidity and mortality. A direct relationship has been established between weight loss and improvement of metabolic disorders such as hypertension, diabetes mellitus, lipid metabolism, sleep apnea, and comorbidities - nonalcoholic fatty liver disease. polycystic ovary syndrome, infertility. Bariatric surgery is the most effective treatment for obesity. Remission of diabetes results from improved β-cell function, increased insulin sensitivity, and changes in the gut and adipose tissue. Compared to intensive medical treatment and lifestyle intervention, metabolic surgery has shown superiority in improving glycemia, reducing medications, and reducing cardiovascular risk factors, implying long-term benefits. on cardiovascular morbidity and mortality.

Downloads

Download data is not yet available.

References

Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, ეტ ალ/ Global, regional, and national prevalence of overweight and obesity in children and adults during 12013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Aug 30;384(9945):766-81. doi: 10.1016/S0140-6736(14)60460-8. Epub 2014 May 29. Erratum in: Lancet. 2014 Aug 30;384(9945):746. PMID: 24880830; PMCID: PMC4624264.

Cătoi AF, Pârvu A, Mureşan A, Busetto L. Metabolic Mechanisms in Obesity and Type 2 Diabetes: Insights from Bariatric/Metabolic Surgery. Obes Facts. 2015;8(6):350-63. doi: 10.1159/000441259. Epub 2015 Nov 20. PMID: 26584027; PMCID: PMC5644813.

American Diabetes Association, Summary of Revisions: Standards of Care in Diabetes—2023. Diabetes Care 1 January 2023; 46 (Supplement_1): S5–S9.

Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014 Sep 3;312(9):934-42. doi: 10.1001/jama.2014.10706. PMID: 25182102; PMCID: PMC4409000.

Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014 Jan;22(1):5-13. doi: 10.1002/oby.20662. PMID: 24307184; PMCID: PMC3904491.

BARNES CG. Hypoglycaemia following partial gastrectomy; report of three cases. Lancet. 1947 Oct 11;2(6476):536-9. doi: 10.1016/s0140-6736(47)90584-9. PMID: 20265182.

BARNES CG. Hypoglycaemia following partial gastrectomy; report of three cases. Lancet. 1947 Oct

Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. doi: 10.2337/dc08-s265. PMID: 18227496.

Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, De Luca M, Faria SL, Goodpaster KPS, Haddad A, Himpens JM, Kow L, Kurian M, Loi K, Mahawar K, Nimeri A, O'Kane M, Papasavas PK, Ponce J, Pratt JSA, Rogers AM, Steele KE, Suter M, Kothari SN. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery.

Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Chen SC, Lee YC, Ser KH. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surgery for Obesity and Related Diseases. 2013 May 1;9(3):379-84.

Aron-Wisnewsky J, Sokolovska N, Liu Y, Comaneshter DS, Vinker S, Pecht T, Poitou C, Oppert JM, Bouillot JL, Genser L, Dicker D. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass. Diabetologia. 2017

Pucci A, Tymoszuk U, Cheung WH, Makaronidis JM, Scholes S, Tharakan G, Elkalaawy M, Guimaraes M, Nora M, Hashemi M, Jenkinson A. Type 2 diabetes remission 2 years post Roux‐en‐Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores. Diabetic Medicine. 2018 Mar;35(3):360-7.

Aminian A, Brethauer SA, Andalib A, Nowacki AS, Jimenez A, Corcelles R, Hanipah ZN, Punchai S, Bhatt DL, Kashyap SR, Burguera B. Individualized metabolic surgery score: procedure selection based on diabetes severity. Annals of surgery. 2017

Taylor R. Banting Memorial lecture 2012: reversing the twin cycles of type 2 diabetes. Diabet Med. 2013 Mar;30(3):267-75. doi: 10.1111/dme.12039. PMID: 23075228; PMCID: PMC3593165.

Manning S, Pucci A, Batterham RL. Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Invest. 2015 Mar

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, Upadhyay J, Alexandrou A, Mantzoros CS. Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: Evidence from two independent trials. Metabolism. 2019 Dec;101:153997. doi: 10.1016/j.metabol.2019.153997. Epub 2019 Oct 28. PMID: 31672446.

Perakakis N, Mantzoros CS. The role of glicentin and oxyntomodulin in human metabolism: new evidence and new directions. The Journal of Clinical Endocrinology & Metabolism. 2020 Aug;105(8):e3003-5.

Nielsen MS, Ritz C, Wewer Albrechtsen NJ, Holst JJ, le Roux CW, Sjödin A. Oxyntomodulin and glicentin may predict the effect of bariatric surgery on food preferences and weight loss. The Journal of Clinical Endocrinology & Metabolism. 2020 Apr;105(4):e1064-74.

Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, Shi J, Zhao S, Liu W, Wang X, Xia H, Liu Z, Cui B, Liang P, Xi L, Jin J, Ying X, Wang X, Zhao X, Li W, Jia H, Lan Z, Li F, Wang R, Sun Y, Yang M, Shen Y, Jie Z, Li J, Chen X, Zhong H, Xie H, Zhang Y, Gu W, Deng X, Shen B, Xu X, Yang H, Xu G, Bi Y, Lai S, Wang J, Qi L, Madsen L, Wang J, Ning G, Kristiansen K, Wang W. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017 Jul;23(7):859-868. doi: 10.1038/nm.4358. Epub 2017 Jun 19. PMID: 28628112.

Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J, Bonab AA, Fischman AJ, Yarmush ML, Stylopoulos N. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science. 2013 Jul

Pérez-Pevida B, Escalada J, Miras AD, Frühbeck G. Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery. Front Endocrinol (Lausanne). 2019

Downloads

Published

2024-11-15

How to Cite

Shervashidze, T., Kvanchakhadze, R., Abuladze, D., & Jashi, L. (2024). Mechanisms of Type 2 Diabetes Remission After Bariatric and Metabolic Surgery. Scientific Journal „Spectri“, 9(1). https://doi.org/10.52340/spectri.2024.09.01.22

Issue

Section

Articles
Loading...